NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/20/2024
Back to search
Official data from USPTO
ZELVYKTA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ZELVYKTA
ST13
US500000097693443Class
5, 10, 44
Filing
97693443
Registration
7477787
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
08/20/2024
Trademark type
Word
Nice classes
5, 10, 44
Filing date
11/28/2022
Registration date
08/20/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/20/2024
Last transaction
08/20/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
99
Owner location
Søborg, DK
Examiner
CANTOR, JILLIAN
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Zealand Pharma A/S
Representatives
Shannon Marie McKeon DYKEMA GOSSETT PLLC
Technical classification
Nice Classes
Class 5Class 10Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of human patients suffering from congenital hyperinsulinism and/or hypoglycemia; Medical preparations for the treatment of human patients suffering from congenital hyperinsulinism and/or hypoglycemia
Class 10
Infusion pumps; medical devicesinfusion pumps for subcutaneous delivery of drugs; medical apparatusinfusion and injection devices for administering drugs; medical apparatusinfusion and injection devices for administering drugs for the treatment of congenital hyperinsulinism; medical apparatusinfusion and injection devices for administering drugs for the treatment of hypoglycemia; Infusion and injection devices for administering drugsparts and fitting thereforesold as a unit; Infusion pumps and parts and fittings for infusion pumps sold as a unit
Class 44
Medical services relating to treatment of human patients suffering from congenital hyperinsulinism and/or hypoglycemia
Publications
History of USPTO decisions and trademark events.
21 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/20/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/04/2024
PUBO
PUBLISHED FOR OPPOSITION
06/04/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/15/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/30/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
04/30/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/30/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
04/30/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/30/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/16/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/16/2024
ALIE
ASSIGNED TO LIE
04/16/2024
DOCK
ASSIGNED TO EXAMINER
03/18/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/27/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/07/2023
GNRT
NON-FINAL ACTION E-MAILED
09/07/2023
CNRT
NON-FINAL ACTION WRITTEN
09/07/2023
DOCK
ASSIGNED TO EXAMINER
09/07/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/20/2022
NWAP
NEW APPLICATION ENTERED
12/01/2022
Continuous trademark protection
Get notified about every new filing that threatens ZELVYKTA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.